what are glp 1 ras Transformation 2.0: The GLP-1 as Psychiatric Medications? Central glucagon-like peptide 1 receptor

Eli Lilly delivered a Q1 2026 trifectaearnings beat, raised full-year guidance, and early-April FDA approval of Foundayo, the first oral GLP-1 with no food or water restrictionswidening its lead over Novo Nordisk just as the race for a convenient weight-loss pill heats up

That spread likely reflects promotional introductory pricing, dose changes, and how fast this space moves rather than any single source being wrong

There are two major drivers of GLP-1 discontinuation in typical care: tolerability issues and insufficient behavioral support

However, that doesn't necessarily guarantee (the pill) is going to be cheaper, she said

80-23) revised in 1996